Mei Baisong

Track

Insider profile

Performance

Overall performance
4.4
Performance over holding periods
4.4
30 days 90 days 120 days
Average return 23% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mei Baisong's trades of Editas Medicine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
315.37
Quantity 92,557 +30.5%
Value US$2,694,929
Transaction date
Proposed sale
Price
321.51
Quantity 63,715
Value US$4,503,230
Transaction date
Proposed sale
Price
5.61
Quantity 14,000
Value US$78,540
Transaction date
Proposed sale
Price
5.32
Quantity 1,000
Value US$5,320
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-05 2024-12-03
S Sale
92,557 +30.5%
315.37
US$2,694,929 		92,557 +30.5% 315.37 US$2,694,929
2024-09-06 2024-09-04
S Sale
20,351 -8.3%
231.74
US$57,209 		20,351 -8.3% 231.74 US$57,209
2024-08-29 2024-09-03
PrS Proposed sale
63,715
321.51
US$4,503,230 		63,715 321.51 US$4,503,230
2024-07-22 2024-07-19
S Sale
6,619 -4.7%
5.21
US$34,456 		6,619 -4.7% 5.21 US$34,456
2024-07-18 2024-07-19
PrS Proposed sale
14,000
5.61
US$78,540 		14,000 5.61 US$78,540
2024-06-06 2024-06-04
S Sale
511 -0.4%
5.50
US$2,808 		511 -0.4% 5.50 US$2,808
2024-05-31 2024-06-03
PrS Proposed sale
1,000
5.32
US$5,320 		1,000 5.32 US$5,320
2024-03-05 2024-03-04
S Sale
20,327 -12.6%
9.42
US$191,425 		20,327 -12.6% 9.42 US$191,425
2023-07-21 2023-07-19
S Sale
4,317 -5.7%
8.80
US$37,990 		4,317 -5.7% 8.80 US$37,990